MBL deficiency compromises the innate immune response, resulting in a higher risk of developing post-transplant CMV disease and increasing the necessity of prophylactic treatment [43]. This evidence concerns the gene MBL2 and hyperinsulinemic hypoglycemia, familial, 4.